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Abstract: Total or partial body irradiation is a distinct risk of accidental,
wartime, or terrorist events. Total body irradiation is also used as conditioning
therapy before hematopoietic stem cell transplantation. This can result in
injury to multiple tissues and may result in death due to multi-organ failure.
The hypothalamic-pituitary-adrenal (HPA) axis could play a causative role in
those injuries, in addition to being activated under conditions of stress. In a
rat model of TBI, we have established that radiation nephropathy is a
significant lethal complication, due to hypertension and uremia. The present
study assessed HPA axis function in rats undergoing total body irradiation
(TBI). Using a head-shielded model of TBI, we found an enhanced response
to corticotropin-releasing hormone (CRH) in vitro in pituitaries from irradiated
compared to non-irradiated rats at both eight and seventy days after 10 Gy
single fraction TBI. At seventy, but not eight days, plasma ACTH and
corticosterone levels were significantly increased in irradiated compared to
non-irradiated rats. Plasma aldosterone was not affected by TBI at either time
point, while plasma renin activity was decreased in irradiated rats at 8 days.
Basal and stimulated adrenal steroid synthesis in vitro was not affected by
TBI. In addition, plasma epinephrine was decreased at 70 days after TBI.
Hypothalamic expression of CRH mRNA and hippocampal expression of
glucocorticoid receptor mRNA were unchanged by irradiation. We conclude
that the hypertension of radiation nephropathy is not aldosterone or
catecholamine-dependent, but that there is an abscopal activation of the HPA
axis after 10 Gy TBI. This activation was at least partially attributable to
enhanced pituitary ACTH production.

Introduction
Illness after total body irradiation (TBI) is complex, and can
present as multi-organ injury (1). The hypothalamic-pituitary-adrenal
(HPA) axis could play a significant causative or reactive role in this
multi-organ injury. There have been limited studies on the effects of
TBI on the HPA axis. In humans undergoing TBI for hematopoietic
stem cell transplantation, acute increases in plasma ACTH have been
reported at four hours after TBI (2). Rats undergoing 1 to 10 Gy TBI
showed increased plasma ACTH and corticosterone at one hour to
three days after TBI (3–5). This suggests pituitary-adrenal activation
soon after TBI. Changes in the HPA axis at later times have not been
thoroughly studied.
In preliminary studies, we have found an increase in urinary
aldosterone and corticosterone excretion between one and ten weeks
after 10 Gy TBI in rats (unpublished). This could contribute to the
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hypertension of radiation nephropathy, either through aldosterone
itself or via mineralocorticoid effects of corticosterone. Additional
complications of TBI, such as osteopenia or impaired hippocampal
neurogenesis, could also be caused by an activated HPA axis. These
studies were designed to test whether TBI activates the HPA axis in
rats. The effects of TBI were assessed by measuring plasma
hormones, evaluating in vitro hormone production, and quantifying the
expression of pertinent genes.

Methods
Radiation model
WAG/Rij/MCW male rats aged 5 to 8 weeks were maintained on
sterilized rat chow in a moderate-security barrier facility at the
Biomedical Resource Center of the Medical College of Wisconsin (MCW)
(Milwaukee, WI, USA). Rats received TBI with a single dose of 10 Gy
with a posterior-anterior field at a dose rate of 1.95 Gy/min. This dose
was chosen because it is a dose that has been used clinically and
because we have ample data in this model at this dose. Irradiation was
with 300 kVp orthovoltage x-rays, with a half value layer of 1.4 mm
Cu. The heads were protected by a lead shield that reduced the
radiation dose by over 98%; this prevents long term buccal and
salivary gland injury. The brain and pituitary gland are shielded in this
model. The use of a barrier facility eliminated the risk of infectious
morbidity and mortality. One to 2 hr after TBI, rats were given fresh
bone marrow cells from a syngeneic littermate as previously published
(6). The bone marrow cells prevent hematologic death from the TBI,
and the use of a syngeneic donor avoids graft versus host disease.
Control rats were sham-irradiated and did not receive a bone marrow
transplant. In this model, there is reduced food intake during the first
week after TBI. The animals then recover, gain weight, and are
apparently healthy until they become hypertensive and uremic at three
months or more after TBI. A standard rodent diet (Harlan Teklad 8604,
25% protein and 0.3% sodium) and water were provided ad libitum.
Rats were housed two per cage on a 12 hour light-dark cycle at an
ambient temperature of 21 degrees C. Rats were handled daily on the
three days before experimentation in order to minimize stress
responses at the time of sacrifice. Rats were sacrificed by rapid
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decapitation at 8 or 70 days after TBI, all between 8 and 9 a.m. The
eight and seventy day time points are within the latent period where
there is little evidence for radiation injury in this model. Thus,
detectable abnormalities at these time points are highly relevant to the
mechanisms of injury. Animal care was in accordance with NIH
guidelines. The Animal Care and Use Committee at the MCW approved
all procedures, which were done in accord with its ethical guidelines. .
Eight irradiated and eight non-irradiated rats were sacrificed on
each study day. Trunk blood was obtained from all rats. Four pituitary
glands from each group were placed in liquid nitrogen and four were
placed in ice-cold buffer. Twelve adrenal glands from each group were
placed in ice-cold buffer, and four were placed in liquid nitrogen.
Brains were frozen in methylbutane on dry ice, and then kept frozen
on dry ice. All frozen tissue was subsequently stored in a −70° freezer
until further analysis.

Plasma hormone levels
Plasma ACTH, corticosterone, and aldosterone were measured
by radioimmunoassay as described previously (7). Plasma renin
activity was measured as angiotensin I generation in vitro as described
previously (8). Plasma catecholamines were measured by HPLC and
electrochemical detection as described previously (9). Rat plasma
angiotensinogen (Agt) was measured by ELISA (IBL, Gunma, Japan).
Standards ranged from 0.08 to 5.0 ng/ml. Plasma samples were
diluted 1:3100 and are reported in μg/ml.

Pituitary ACTH secretion in vitro
Pituitary corticotroph function was assessed by measurement of
basal and CRH-stimulated ACTH release from pituitary fragments in
vitro as described previously (10).

Adrenocortical steroid synthesis in vitro
Adrenal steroidogenesis was assessed by measurement of basal
and stimulated aldosterone release from dispersed zona glomerulosa
cells (adrenal capsules), and basal and stimulated corticosterone
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release from dispersed zona fasciculata/reticularis cells (adrenal
subcapsules) as described previously (11).

Pituitary and adrenal gene expression
CRH receptor and pro-opiomelanocortin (POMC) mRNAs were
analyzed by qPCR of frozen anterior pituitaries. Essential components
of the adrenal steroidogenic pathway were evaluated by measurement
of LDL receptor, StAR, P450scc, and late pathway enzyme mRNAs by
qPCR of frozen adrenal glands (12). Total RNA for real-time PCR was
isolated from adrenal glands (1 adrenal per group per experimental
day) and anterior pituitaries (4 pooled pituitaries per group per
experimental day) using the RNeasy Mini Protocol (Qiagen). The
concentration of RNA was quantified using a Qubit Fluorometer
(Invitrogen Corporation, Carlsbad, CA). All RNA samples were diluted
to a final concentration of 10–20 ng/μL in the PCR assay. Real-time
PCR was performed using the Taqman One-Step RT-PCR protocol and
pre-made primers and probes (Applied Biosystems, Inc., Foster City,
CA). Primer/probe sets are listed in Table 1. The final reaction volume
of 20 uL consisted of 1X AmpliTaq Gold® DNA Polymerase mix, 1X RT
enzyme mix containing MultiScribe™ Reverse Transcriptase and RNase
Inhibitor, 1X primer/probe mix, and 50–100 ng of total RNA.
Amplification and detection were performed with the ABI Prism
7900HT Sequence Detection System with the following thermal cycler
conditions: 48 ºC for 30 min (RT), 95 ºC for 10 min, and 40 cycles at
95 ºC for 0.25 min and 60 ºC for 1 min. Each sample was assayed in
triplicate. Gene expression was quantified using the number of cycles
to reach a predetermined threshold value in the intensity of the PCR
signal (the Ct value).
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Brain studies
In situ hybridization histochemistry (ISHH) was used to assess
hypothalamic paraventricular (PVN) CRH mRNA and hippocampal
glucocorticoid receptor mRNA expression as described previously (13–
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15). All ISHH data were analyzed by digitizing the X-ray images, with
optical densities measured using NIH Image software (courtesy W.
Rasband; http://rsb.info.nih.gov/nih-image). For each section,
background optical density was measured in white matter (corpus
callosum) and subtracted from raw density measurements for CRH or
GR mRNA signal to yield “corrected gray level.” For CRH mRNA, data
from 2–3 sections per rat were averaged; for GR mRNA, 2–4 sections
were averaged.

Statistical Analyses
Body weight and plasma hormone data were analyzed by twofactor analysis of variance (days after ±TBI vs. ±TBI) followed by
Duncan’s multiple range test (Sigmastat 3.0). ACTH secretion from
pituitary fragments was analyzed by three-factor analysis of variance
(±CRH vs. ±TBI vs time after TBI) followed by Duncan’s multiple
range test. qPCR data were analyzed by t-test. The observed
corticosterone and aldosterone levels were log-transformed to allow
modeling of multiplicative effects (fold-changes in hormone
production) and improve normality of the residuals. We tested whether
the production of corticosterone or aldosterone differs between
irradiated and non-irradiated rats, at 8 days and also at 70 days, using
a paired t-test on the unstimulated observations. We also tested
whether the stimulatory effect of ACTH and cAMP on corticosterone or
aldosterone differs, between irradiated and non-irradiated rats, at 8
days and also at 70 days. For this analysis we fit a mixed model with
fixed effects for the drug, radiation group, and their interaction, and a
random intercept for each experimental run. This takes into account
the repeated measurements for each experiment, and adjusts for
different baseline rate of hormone production in each run. For each of
the four outcomes (the log of ACTH vs corticosterone, ACTH vs.
aldosterone, cAMP vs corticosterone and cAMP vs aldosterone) the
hypothesis of interest is the presence of interaction of either ACTH or
cAMP and treatment (radiation vs. no radiation). Adrenal cell statistical
analyses were performed using SAS 9.2 (SAS Institute, Cary, NC).
Results
Irradiated rats gained less weight than non-irradiated rats, as
previously reported for this model (16) (Figure 1). Two of 86 irradiated
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rats died before the 70 day time point. Plasma ACTH, corticosterone,
and aldosterone concentrations did not differ between irradiated and
non-irradiated rats at 8 days after TBI (Figure 2). At 70 days after TBI,
plasma ACTH and corticosterone concentrations were significantly
higher in the irradiated compared to the non-irradiated rats. Plasma
renin activity was lower at the 8-day time point in irradiated compared
to non-irradiated rats; at 70 days after TBI, plasma renin activity was
not different between irradiated and non-irradiated rats. Plasma
angiotensinogen (Agt) concentrations (N=12–13 per group) were
unaffected by TBI. Plasma Agt at 8 days after TBI was 4.0± 0.4 μg/ml
compared to 4.5±0.5 μg/ml in unirradiated rats. Plasma Agt at 70
days after TBI was 5.2±0.8 μg/ml compared to 4.9±0.3 μg/ml in
unirradiated rats. Plasma aldosterone did not differ at the 70-day time
point. There was no effect of irradiation on norepinephrine levels at
either time point, whereas epinephrine levels were significantly lower
in irradiated rats at 70 days after TBI (Figure 3).

Figure 1

Body weights in the eight and seventy day unirradiated and irradiated

rats. + indicates a significant difference from the corresponding value at the different
time point, and * indicates a significant difference from the control value at the same
time point, both p<0.05. N=32 (4 experimental days) for the eight day time point,
and n=48 (six experimental days) for the 70 day time point.
Translational Research, The Journal of Laboratory and Clinical Medicine, Vol. 157, No. 1 (January 2011): pg. 38-47. DOI.
This article is © Elsevier and permission has been granted for this version to appear in e-Publications@Marquette.
Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Elsevier.

8

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 2

Plasma hormone levels at eight and seventy day rats after TBI. +

indicates a significant difference from the corresponding value at the different time
point, and * indicates a significant difference from the control value at the same time
point, both p<0.05. N=24 (six experimental days) for the eight day time point, and n=
20 (five experimental days) for the seventy day time point.

Figure 3

Plasma catecholamine levels at eight and seventy day rats after TBI. +

indicates a significant difference from the corresponding value at the different time
point, and * indicates a significant difference from the control value at the same time
point, both p<0.05. N=22 (six experimental days) for the eight day time point, and
n=20 (five experimental days) for the seventy day time point.

Pituitary glands from irradiated rats evaluated in vitro had
significantly increased basal and CRH-stimulated ACTH secretion
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compared to non-irradiated rats at both 8 and 70 days after TBI (p <
0.001; Figure 4). The effect of time after TBI was not significant (p =
0.102). None of the interaction terms in the 3-factor analysis of
variance were significant (p = 0.464–0.828) indicating that the TBIinduced increase basal and CRH-stimulated ACTH secretion
represented a parallel shift. Unstimulated and cAMP-stimulated (Figure
5) and ACTH-stimulated (not shown) corticosterone and aldosterone
release from adrenal cells in vitro were not altered by TBI at either
time point.

Figure 4

Basal and CRH-stimulated ACTH release by pituitary fragments in vitro. +

indicates a significant difference from the corresponding unstimulated value, and *
indicates a significant difference of the irradiated values compared to the nonirradiated
ones, both p<0.05. N=5 experimental days for the eight and seventy day time points.
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Figure 5

Basal and cAMP-stimulated adrenal steroid synthesis by adrenal

fragments in vitro. * indicates a significant difference from the corresponding
unstimulated value, p<0.05. N=5 experimental days for the 8- and 70-day time
points.

In situ hybridization studies of the brain showed no effect of TBI
with head shield on the expression of CRH mRNA in the paraventricular
nucleus, or glucocorticoid receptor mRNA in the hippocampus (Table
2). Further, there were no significant differences between irradiated
and non-irradiated rats for pituitary POMC or CRH receptor-1 mRNAs
assessed by qPCR, at either 8 or 70 days after TBI (Table 3). Adrenal
mRNAs for steroidogenic factors and enzymes showed no consistent
differences at either time point (Table 3). Modest but significant
increases in mRNAs for catecholamine synthetic enzymes were found
at 8 days in irradiated compared to non-irradiated rats, but not at 70
days.

Translational Research, The Journal of Laboratory and Clinical Medicine, Vol. 157, No. 1 (January 2011): pg. 38-47. DOI.
This article is © Elsevier and permission has been granted for this version to appear in e-Publications@Marquette.
Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Elsevier.

11

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Discussion
There was a significant increase in plasma ACTH and
corticosterone levels at 70 days after TBI in this model of radiation
nephropathy. This is the latest time after TBI that HPA axis stimulation
has been reported, to our knowledge. This effect was not present 8
days after TBI. There was no effect on hypothalamic CRH mRNA or
hippocampal GR mRNA expression. There was significant enhancement
of the in vitro pituitary response to CRH in irradiated rats at both time
points. There was no effect of TBI on basal and stimulated
steroidogenesis in adrenal cells in vitro. Plasma catecholamine levels
were not increased by TBI, and epinephrine was decreased at the 70
day time point.
Over sixty years ago, increased adrenal weight was reported in
rats at one week after 650r TBI (17). Later studies tested adrenal
Translational Research, The Journal of Laboratory and Clinical Medicine, Vol. 157, No. 1 (January 2011): pg. 38-47. DOI.
This article is © Elsevier and permission has been granted for this version to appear in e-Publications@Marquette.
Elsevier does not grant permission for this article to be further copied/distributed or hosted elsewhere without the
express permission from Elsevier.

12

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

function in rhesus monkeys after successive weekly or bimonthly doses
of TBI, and found some evidence for an enhanced adrenal response to
ACTH (18). Plasma corticosterone was increased after 500 r TBI to
rats, at one hour and at two days after irradiation, with similar findings
in mice after 1500 r TBI (19, 20). On the other hand, inhaled
plutonium was reported to cause hypocortisolism in beagles (21). At
the level of the pituitary gland, mice exposed to planned atomic
detonations developed ACTH-secreting tumors (22), while cranial
irradiation of rats at 20 to 24 Gy caused generalized pituitary trophic
hormone deficiencies, including that of ACTH (23). More recently, a
lesser sensitivity to dexamethasone suppression of the HPA axis was
reported at six weeks after 10 Gy whole brain irradiation (24).
Our finding of a late increase in activity of the HPA axis runs
counter to the clinical evidence for central hypoadrenalism after brain
or whole body radiation exposures. This may be the case because this
model does not involve appreciable brain irradiation. The stimulatory
effect of whole body irradiation is thus evident. An increase of plasma
corticosterone was also found after body-only irradiation of burros with
275 cGy and higher doses of fast neutrons (25). ). Use of an
intermediate dose of TBI could show a dose-response effect of HPA
activation, but we did not do those studies.

Mechanism of HPA activation
The mechanism of the increase in plasma ACTH at 70 days postTBI is unknown. The in vitro pituitary cell studies suggest an enhanced
responsiveness to CRH, although a similar enhancement was found at
8 days with no increase in plasma ACTH. A direct effect of brain
irradiation is unlikely, because the heads were shielded. Systemic
effects of irradiation and/or the bone marrow transplant procedure
could be relevant. These might include cytokines such as interleukin-1
or interleukin-6 (2, 5). But the cytokine response to TBI and the
marrow transplant is likely to be dissipated by 70 days. Metabolic
acidosis can elicit ACTH secretion (26) and could exist at the 70 day
time point, because the rats have renal injury and a BUN of ~ 40
mg/dl. Acidosis probably does not explain the enhanced pituitary ACTH
response at the eight day time point, when there is no reduction of
kidney function. A role for energy stores in the HPA axis has been
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proposed (27); in that model, the lesser weight and body fat at the
both the 8 and 70 day time point might lead to a feedback-mediated
increase in ACTH secretion.
The hypothalamic response to TBI was invoked over 50 years
ago as the mechanism whereby TBI caused activation of the HPA axis
(28). The present studies do not show evidence for enhanced
hypothalamic CRH mRNA expression or a change in GR mRNA
expression in the hippocampus as the cause for the activated HPA axis
at 70 days after TBI. A lack of change in CRH or GR mRNA does not
exclude changes in translation or post-translational processing, or a
change in neuronal activity not reflecting in changes in mRNA
expression. It is possible that TBI without head shielding could have a
different effect from that of the present studies. Any direct effect of
pituitary irradiation would have to take into account the findings of the
present study, which suggest an indirect, abscopal stimulatory effect
of TBI on pituitary release of ACTH. The present head-shielded model
is particularly relevant to partial body exposures, as are likely in war,
accident, or dirty bomb events.
Our studies do not replicate those that show an early increase in
plasma ACTH and/or corticosterone after TBI. This may be because
most previous studies did not control for the stress of handling the
animals. By the daily handling of the rats for the three days before
their rapid decapitation, we minimized the confounding acute stressinduced surge of ACTH that could occur. In fact, despite being only 8
days after TBI, BMT, and consequent weight loss associated with those
treatments, plasma ACTH and corticosterone levels were normal,
which shows the general health of these rats.
It is possible that pituitary corticotroph hyperplasia could
underlie the persistent elevation in ACTH at 70 days after TBI. Mice
exposed to atomic detonations can form ACTH-secreting tumors by
two years after radiation exposure (22). But in the present studies,
pituitary tumors were not observed during the dissection. Histological
studies could clarify this issue.
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Consequences of HPA activation
Pituitary-adrenal activation could have beneficial or deleterious
effects. TBI as low as 2 Gy may cause bone thinning in mice (29), and
we have preliminary data in our rats that show a decline in trabecular
number after 10 Gy TBI (Bateman, personal communication).
Increased corticosterone concentrations could certainly reduce bone
mass. Increased corticosterone levels could also influence radiation
nephropathy. Two of the three reported studies of attempted
treatment of radiation nephropathy with corticosteroids have reported
a poorer outcome (30–32). Thus, increased plasma corticosterone at
70 days after TBI could worsen the observed renal injury. Finally, the
doubling of plasma corticosterone in our study may have led to an
attenuation of hippocampal neurogenesis, an effect that would be
additive to that of radiation itself when using TBI without head
shielding.
The increase in ACTH and corticosterone at 70 days occurred at
a time when rats in this model show renal injury. Proteinuria is evident
by 40 days after 10 Gy TBI, azotemia soon after that, and the systolic
blood pressure is significantly elevated by 70 days (33). It is possible
that the increase in plasma corticosterone plays a role in the increase
in blood pressure. This could depend on the activity of renal11-beta
hydroxysteroid dehydrogenase type 2 and enhanced corticosteroneinduced activation of the mineralocorticoid receptor. We have no
information on the activity of this enzyme in this model. Its gene
expression was not reported as changed in a gene array study of
irradiated mouse kidney (34). At this time point in our study, plasma
aldosterone was higher than it was in the unirradiated rats, but just
short of statistical significance. It appears unlikely that the
hypertension in this model of radiation nephropathy depends on
plasma aldosterone.

Unexplained findings
There are aspects of the TBI model that are not explained by
the increase in ACTH and corticosterone at 70 days. Rats undergoing
TBI at doses of 6 Gy and above have a significantly lower weight gain
and body fat than their un-irradiated littermates (16). One might
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expect greater weight gain and increased body fat in a state of
hypercortisolism and ad lib food intake. As described above, activation
of the HPA axis could result from a negative energy balance caused by
other factors after TBI.
The modest but significant increase in adrenal medullary genes
for catecholamine synthesis at 8 days is unexplained. Hasan et al.
showed some evidence for adrenal medullary cell degranulation and an
increase in blood epinephrine and norepinephrine at 14 days after 600
r to male rats (35). Older data suggest that the adrenal medulla is
radioresistant (36). The gene expression data notwithstanding, we did
not find increased plasma catecholamines 8 days after TBI, and there
was actually a decrease in plasma epinephrine at day 70 in these
studies. Therefore, the hypertension in our model of radiation
nephropathy does not seem to involve increased plasma
catecholamines.
We have previously found that plasma renin was unchanged for
up to 9 weeks after 17 Gy TBI given in six fractions (33). That
irradiation schedule is very similar in its biological effect to the 10 Gy
single fraction TBI used in the present studies. It is not clear why we
found significantly lower PRA at 8 days in the present studies. It was
not due to differences in plasma angiotensinogen concentrations.
Extracellular volume expansion is unlikely, since the rats usually have
a lower oral intake at this time. Hypertension is not observed in this
model until nine weeks or more after TBI. Thus, hemodynamic causes
for renin suppression appear unlikely. Plasma catecholamines were
unchanged, so their role in causing this low PRA is unlikely. In
previous studies, we have found neither serum nor intrarenal increases
in Ang II (33), which reduces the likelihood that an increase in Ang II
would cause the lower PRA. Injury to the juxtaglomerular apparatus
was reported after 11 Gy renal irradiation to rats (37), so that a direct
injury to renin-producing cells in the kidney is possible. The origin of
the higher PRA at 70 days after irradiation is also unexplained. At this
time, the animals begin to have an increase in blood pressure, and the
increased PRA could play a role in causing that hypertension. There is
a parallel trend for a higher plasma aldosterone at the 70-day time
point (Figure 3), but this was not statistically significant. We have
tested the role of spironolactone in this model and found it to have no
effect to mitigate renal injury or to significantly lower the blood
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pressure (38). Therefore, neither an increased plasma renin activity
nor an increased plasma aldosterone explains the pathophysiology of
this model of radiation nephropathy.

Conclusions
We have found that there is a pituitary-dependent activation of
the HPA axis at 70 days after 10 Gy total body irradiation in rats. This
appears to be an indirect, abscopal effect of whole body irradiation. It
is possible that the ACTH-mediated increase in plasma corticosterone
at this time may contribute to impaired neurogenesis and osteopenia,
and may complicate other organ injuries after TBI. On the other hand,
there is no evidence of HPA axis activation in vivo at 8 days after 10
Gy TBI, which belies the notion of a generalized stress response to
irradiation at this early time point. Finally, changes in renin,
aldosterone, and catecholamines do not appear to explain the
development of hypertension that is a well-established feature of this
model.
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